New Treatment for Parkinson’s Disease Developed at NTHU

HSINCHU, Taiwan–(BUSINESS WIRE)–Mar. 12, 2020 Ultrasound is widely used for conducting physical examinations, and plans are underway for expanding its application to the treatment of Parkinson's disease, dementia, and diabetes. A research team at National Tsing Hua University led by Associate Professor Yu-Chun Lin of the Institute of Molecular Medicine and Professor Chih-kuang Yeh of […]

Takeda Agrees to Divest Select OTC and Non-Core Assets in Latin America to Hypera Pharma for $825 Million USD

− Company further sharpens focus on patient access to innovative medicines in Latin America − Transaction further accelerates deleveraging OSAKA, Japan–(BUSINESS WIRE)–Mar. 02, 2020 Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select non-core products exclusively in Latin America to Hypera S.A. (“Hypera Pharma”), Brazil’s […]

Takeda Completes Sale of Select OTC and Non-Core Assets to Acino

OSAKA, Japan–(BUSINESS WIRE)–Mar. 02, 2020 Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of select over-the-counter (OTC) and prescription pharmaceutical assets in a number of Near East, Middle East and Africa countries within its Growth and Emerging Markets Business Unit (GEM BU) to Acino for a […]

New Cancer Treatment Developed at NTHU

HSINCHU, Taiwan–(BUSINESS WIRE)–Feb. 27, 2020 A research team led by Dr. Yunching Chen and Tsai-Te Lu of National Tsing Hua University have recently developed a new treatment for cancer, in which blood vessels within malignant tumors are normalized by injecting a specially developed nanodelivery system for nitric oxide (NanoNO), which also facilitates the delivery of […]

Aptorum Group Commences Commercialization of Dioscorea Opposita Bioactive Nutraceutical Tablets and Signed Sales Distribution Agreement in Hong Kong

NEW YORK–(BUSINESS WIRE)–Feb. 24, 2020 Aptorum Group Limited (“Aptorum Group”), a pharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces the commercialization of its dietary supplement for women undergoing menopause and experiencing related symptoms. The supplement is made with the bioactive ingredient extracted Chinese yam powder containing “DOI”, […]

Aptorum Group Announces Significant Progress of Repurposed Drug Candidate SACT-1 for Neuroblastoma Targeting IND Submission in H2 2020

NEW YORK–(BUSINESS WIRE)–Feb. 10, 2020 Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces positive data and development in relation to its repurposed drug candidate, SACT-1, for the treatment of neuroblastoma, a rare type of childhood cancer that develops in […]

Aptorum Group Announces Further Positive Data For Its ALS-4 Small Molecule Anti-virulence (Non-bactericidal) Drug Candidate For The Treatment of Infections Caused By Staphylococcus Aureus and On Track Targeted For IND Submission in H2 2020

NEW YORK–(BUSINESS WIRE)–Feb. 10, 2020 Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces further positive data from its current investigational new drug (IND)-enabling studies for ALS-4, a small drug molecule candidate indicated for the treatment of infections caused by […]

Jabil Launches Jabil Healthcare the Largest Healthcare Manufacturing Solutions Provider

Jabil combines Nypro with its Orthopedics, Spine, Trauma, and associated medical instruments businesses to deliver unmatched depth and breadth of advanced manufacturing solutions and innovative technical capabilities ST. PETERSBURG, Fla.–(BUSINESS WIRE)–Feb. 03, 2020 Jabil Inc. (NYSE: JBL) today announced the consolidation of its entire healthcare organization under Jabil Healthcare, led by Steve Borges, CEO and […]

Ferring’s Propess® is the first pharmacological treatment for cervical ripening to be appr oved in Japan for over 20 years

Ferring announces that the Minister of Health, Labour and Welfare (MHLW) in Japan has approved Propess® (dinoprostone) for the initiation of cervical ripening1 Propess, developed in Scotland, UK, and marketed in over 60 countries, was approved following close collaboration with the patient community in Japan This approval provides women in Japan with greater choice and is […]

Macrogen Research Outcome from ‘GenomeAsia 100K’ Covered in Nature

The largest number of regions and races included in any Asian reference panel Identification of genome diversity within Asian ethnic groups and differences in drug response SEOUL, South Korea–(BUSINESS WIRE)–Dec. 05, 2019 The precision medicine and biotechnology company Macrogen (Chairman Jung-Sun Seo, www.macrogen.com) (KOSDAQ: 038290) announced on Dec 5 that the result of its Asian genome analysis, which […]

Macrogen: Successful Construction of the Largest Northeast Asian Reference Panel

Reference panel expected to contribute to discover the Northeast Asian specific illness-related genes, and to develop tailored diagnosis method A second reference panel from 10,000 individuals will release early next year SEOUL, South Korea–(BUSINESS WIRE)–Nov. 29, 2019 The joint research team from Seoul National University Bundang Hospital and Macrogen (www.macrogen.com) (KOSDAQ: 038290) announced the release […]